Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC最新文献

{"title":"Guideline No. 461: The Management of Uterine Fibroids.","authors":"Innie Chen, Sari Kives, Elizabeth Randle, Darrien Rattray, Ari Sanders, George Vilos","doi":"10.1016/j.jogc.2025.102970","DOIUrl":"https://doi.org/10.1016/j.jogc.2025.102970","url":null,"abstract":"<p><strong>Objective: </strong>To provide clinicians with an understanding of the clinical significance of fibroids for individuals with uteruses and provide evidence-based guidance on currently available treatment options.</p><p><strong>Target population: </strong>This clinical practice guidelines seeks to improve the lives of individuals with uterine fibroids and fibroid-associated menstrual bleeding or pressure symptoms. Fertility considerations are not discussed in detail, as they are described in the SOGC's Clinical Practice Guideline on The Management of Uterine Fibroids in Women with Otherwise Unexpected Infertility guideline.¹ OPTIONS: This guideline reviews the available medical and surgical management options available for treatment of fibroid-related symptoms. Alternate procedural options, such as uterine artery embolization and energy-based treatment options are also reviewed.</p><p><strong>Outcomes: </strong>This clinical practice guideline is intended to facilitate the decision-making process between patients and healthcare providers regarding the assessment and management of symptomatic uterine fibroids.</p><p><strong>Benefits, harms, and costs: </strong>A majority of fibroid patients are asymptomatic and require no intervention. For patients with abnormal uterine bleeding, iron deficiency anemia, or pelvic pain or pressure symptoms, selected treatment should take into consideration fibroid characteristics and be directed towards patient symptoms and fertility goals. The cost of therapy to the healthcare system for individuals with fibroids must be interpreted in the context of the economic burden, lost productivity, and adverse impacts on quality of life that can be associated with untreated disease.</p><p><strong>Evidence: </strong>This clinical practice guideline is an update of the SOGC's Clinical Practice Guideline No. 318 on The Management of Uterine Leiomyomas.⁴ Using relevant MeSH headings and keywords, published literature was retrieved through searches of PubMed and Cochrane Systematic Reviews the date of last search in February 2013 to January 2025. Grey literature was identified through searching the websites of health technology assessment and health technology-related agencies, clinical practice guideline collections, and national and international medical specialty societies.</p><p><strong>Validation methods: </strong>A national panel of patient partners were gathered to provide feedback and perspective on the recommendations and summary statements for this guideline. Patient partners were purposefully selected to ensure representation of Canadian geographic region, racial representation, and fibroid-related symptom and treatment received.</p>","PeriodicalId":520287,"journal":{"name":"Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC","volume":" ","pages":"102970"},"PeriodicalIF":0.0,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144500207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Examining the relationship between eating disorders and gestational weight gain: A systematic review.","authors":"Kristyn Reeves, Helena Piccinini-Vallis","doi":"10.1016/j.jogc.2025.102964","DOIUrl":"10.1016/j.jogc.2025.102964","url":null,"abstract":"<p><strong>Objective: </strong>Pregnant women face significant changes in their body image, weight, and overall appearance, potentially leading to the development of an eating disorder or exacerbation of a pre-existing eating disorder during pregnancy. Despite the known risks of insufficient or excess gestational weight gain (GWG), few studies have examined the relationship between eating disorders and GWG. The objective of this study was to examine the relationship between GWG and eating disorders in women with anorexia nervosa, bulimia nervosa, and binge-eating disorder.</p><p><strong>Data sources: </strong>CINAHL, Embase, PsycInfo, and PubMed.</p><p><strong>Study selection: </strong>A search strategy was developed and entered into CINAHL, Embase, PsycInfo, and PubMed studies published since 1994 that included participants with a singleton pregnancy, a clinical diagnosis of anorexia nervosa, bulimia nervosa, or binge-eating disorder, and ≥18 years of age.</p><p><strong>Data extraction & synthesis: </strong>Titles and abstracts were reviewed followed by full text review and a quality assessment. An integrated approach was undertaken including line-by-line coding of eligible papers, development of preliminary descriptive themes based on these codes, and amalgamation of the themes to describe the relationship between eating disorders and GWG. 1471 articles were identified, 14 of which met the inclusion criteria for the study. Three themes emerged: body image concerns, fear of GWG and postpartum weight retention, and prioritizing the health of the baby.</p><p><strong>Conclusions: </strong>The identified themes inform the relationship between anorexia nervosa, bulimia nervosa, and binge eating disorder and guideline-discordant GWG. These findings are relevant for individuals who provide prenatal care to patients with previous or current eating disorders.</p>","PeriodicalId":520287,"journal":{"name":"Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC","volume":" ","pages":"102964"},"PeriodicalIF":0.0,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144337428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Episiotomy as a Strategy to Minimize OASIS Risk.","authors":"Chelsea Harris, Jocelyn Stairs","doi":"10.1016/j.jogc.2025.102931","DOIUrl":"https://doi.org/10.1016/j.jogc.2025.102931","url":null,"abstract":"","PeriodicalId":520287,"journal":{"name":"Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC","volume":" ","pages":"102931"},"PeriodicalIF":0.0,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144145104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Preeclampsia Prediction Transformed: The Promise of Arterial Stiffness Short title (max 50 characters): Arterial Stiffness for Preeclampsia Prediction.","authors":"Brenda Valdes Sustaita, Elspeth Skeats, Mekayla Forrest, Maria Matossian, Helena Papacostas Quintanilla, Christian Delles, Stella S Daskalopoulou","doi":"10.1016/j.jogc.2025.102820","DOIUrl":"https://doi.org/10.1016/j.jogc.2025.102820","url":null,"abstract":"","PeriodicalId":520287,"journal":{"name":"Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC","volume":" ","pages":"102820"},"PeriodicalIF":0.0,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143733795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Content, Quality, and Reliability of Endometriosis Videos on YouTube.","authors":"Alexandra McGough, Rebecca J Schneyer, Kacey M Hamilton, Gabriel Levin, Matthew T Siedhoff, Kelly N Wright, Raanan Meyer","doi":"10.1016/j.jogc.2025.102814","DOIUrl":"https://doi.org/10.1016/j.jogc.2025.102814","url":null,"abstract":"<p><p>We aimed to assess the content and quality of YouTube videos about endometriosis. Apify was used to retrieve videos, and 138 videos were included. Most videos originated in high income countries and 50.0% were monetized. Median PEMAT Actionability and Understandability were 95.0 and 100.0, respectively. Median Discern score was 67.5. Compared to other sources, PEMAT Actionability and Discern scores were significantly higher for healthcare professional videos and for videos created from 2021 onward. There was a significant positive association between videos' year of appearance and promotion of endometriosis awareness. In conclusion, endometriosis videos are of high quality, especially when produced by healthcare professionals, endometriosis awareness promotion increases over the years.</p>","PeriodicalId":520287,"journal":{"name":"Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC","volume":" ","pages":"102814"},"PeriodicalIF":0.0,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143639960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Characteristics, Clinical Outcomes and Healthcare Utilization of Women with Cystic Fibrosis and their Live Newborns Delivered in the Hospital Setting.","authors":"Stephanie Y Cheng, Collette Raymond, Laurie Lambert, Farah Husein, Abby McFee, Elizabeth Tullis, Anne L Stephenson","doi":"10.1016/j.jogc.2025.102809","DOIUrl":"https://doi.org/10.1016/j.jogc.2025.102809","url":null,"abstract":"<p><strong>Introduction: </strong>Survival in cystic fibrosis (CF) is increasing and more women are considering their reproductive options, however there is limited data on pregnancy and neonatal outcomes in this population. The objectives of this study were to describe maternal and neonatal outcomes in women with CF and the general Canadian maternal population (general population).</p><p><strong>Methods: </strong>Maternal and neonatal clinical outcomes and healthcare utilization for in-hospital live births was retrieved from the Canadian Institute for Health Information's Discharge Abstract Database. Mothers with CF were identified using the ICD-10-CA code for CF. The observation period was fiscal year (FY) 2006-2007 to FY2020-2021 for mothers with CF, and FY2019-2020 for the general population.</p><p><strong>Results: </strong>During the 15-year observation period, there were 154 newborns from 146 deliveries among 124 mothers with CF. Relative to the general population, mothers with CF were younger (median age 28 vs. 31 years), had more comorbidities, induction of labour, epidural, assisted delivery and use of assisted reproductive technologies, but fewer cesarean sections. Nearly 85% of mothers with CF delivered in a hospital that had a CF clinic. 6.8% of mothers with CF were admitted to the intensive care unit (ICU). Neonates born to mothers with CF had high rates of multiple births, preterm delivery, and jaundice. 26.6% of neonates born to mothers with CF were admitted to the neonatal ICU.</p><p><strong>Conclusions: </strong>While no inferential analyses were done, mothers with CF and their newborns may experience worse post-delivery outcomes and may require greater use of healthcare resources than the general population.</p>","PeriodicalId":520287,"journal":{"name":"Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC","volume":" ","pages":"102809"},"PeriodicalIF":0.0,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143589575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Xylazine: An emerging threat in obstetrics.","authors":"Suzanne Turner, Jocelyn Cook, Lisa Graves","doi":"10.1016/j.jogc.2025.102773","DOIUrl":"https://doi.org/10.1016/j.jogc.2025.102773","url":null,"abstract":"<p><p>Xylazine, an alpha-adrenergic agent, is a common adulterant in the non-prescribed opioid supply. It has multiplicative sedative effects when used with opioids and these effects can negatively impact pregnancy. Given that the opioid epidemic in Canada is not abating and continues to evolve, cases of xylazine exposure during pregnancy are beginning to present in obstetrical units and emergency departments. Rapid dissemination regarding the obstetrical and medical complications that may be seen in patients presenting with unstable opioid use disorders is needed.</p>","PeriodicalId":520287,"journal":{"name":"Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC","volume":" ","pages":"102773"},"PeriodicalIF":0.0,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143070654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.","authors":"François Audibert,&nbsp;Alain Gagnon","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To provide a Canadian consensus document with recommendations on prenatal screening for and diagnosis of fetal aneuploidy (e.g., Down syndrome and trisomy 18) in twin pregnancies.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Options: &lt;/strong&gt;The process of prenatal screening and diagnosis in twin pregnancies is complex. This document reviews the options available to pregnant women and the challenges specific to screening and diagnosis in a twin pregnancy.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Outcomes: &lt;/strong&gt;Clinicians will be better informed about the accuracy of different screening options in twin pregnancies and about techniques of invasive prenatal diagnosis in twins.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Evidence: &lt;/strong&gt;PubMed and Cochrane Database were searched for relevant English and French language articles published between 1985 and 2010, using appropriate controlled vocabulary and key words (aneuploidy, Down syndrome, trisomy, prenatal screening, genetic health risk, genetic health surveillance, prenatal diagnosis, twin gestation). Results were restricted to systematic reviews, randomized controlled trials, and relevant observational studies. Searches were updated on a regular basis and incorporated in the guideline to August 2010. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology assessment-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies. The previous Society of Obstetricians and Gynaecologists of Canada guidelines regarding prenatal screening were also reviewed in developing this clinical practice guideline.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Values: &lt;/strong&gt;The quality of evidence was rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care (Table 1).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Benefits, harms, and costs: &lt;/strong&gt;There is a need for specific guidelines for prenatal screening and diagnosis in twins. These guidelines should assist health care providers in the approach to this aspect of prenatal care of women with twin pregnancies. SUMMARY STATEMENTS 1. Fetal nuchal translucency combined with maternal age is an acceptable first trimester screening test for aneuploidies in twin pregnancies. (II-2) 2. First trimester serum screening combined with nuchal translucency may be considered in twin pregnancies. It provides some improvement over the performance of screening by nuchal translucency and maternal age by decreasing the false-positive rate. (II-3) 3. Integrated screening with nuchal translucency plus first and second trimester serum screening is an option in twin pregnancies. Further prospective studies are required in this area, since it has not been validated in prospective studies in twins. (III) 4. Non-directive counselling is essential when invasive testing is offered. (III) 5. When chorionic villus sampling is performed in non-monochorionic multiple pregnancies, a combination of tra","PeriodicalId":520287,"journal":{"name":"Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC","volume":" ","pages":"754-67"},"PeriodicalIF":1.8,"publicationDate":"2011-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30000875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"SOGC clinical practice guidelines: Canadian contraception consensus.","authors":"Amanda Black,&nbsp;Diane Francoeur,&nbsp;Timothy Rowe,&nbsp;John Collins,&nbsp;Dianne Miller,&nbsp;Thomas Brown,&nbsp;Michèle David,&nbsp;Sheila Dunn,&nbsp;William A Fisher,&nbsp;Nathalie Fleming,&nbsp;Claude A Fortin,&nbsp;Edith Guilbert,&nbsp;Louise Hanvey,&nbsp;André Lalonde,&nbsp;Ruth Miller,&nbsp;Margaret Morris,&nbsp;Teresa O'Grady,&nbsp;Helen Pymar,&nbsp;Thirza Smith,&nbsp;Elke Henneberg","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To provide guidelines for health-care providers on the use of contraceptive methods to prevent pregnancy and sexually transmitted diseases.</p><p><strong>Outcomes: </strong>Overall efficacy of cited contraceptive methods, assessing reduction in pregnancy rate, risk of infection, safety, ease of use, and side effects; the effect of cited contraceptive methods on sexual health and general well-being; and the cost and availability of cited contraceptive methods in Canada.</p><p><strong>Evidence: </strong>Medline and the Cochrane Database were searched for articles in English on subjects related to contraception, sexuality, and sexual health from January 1988 to March 2003, in order to update the Report of the Consensus Committee on Contraception published in May-July 1998. Relevant Canadian Government publications and position papers from appropriate health and family planning organizations were also reviewed.</p><p><strong>Values: </strong>The quality of the evidence is rated using the criteria described in the Report of the Canadian Task Force on the Periodic Health Examination. Recommendations for practice are ranked according to the method described in this Report.</p>","PeriodicalId":520287,"journal":{"name":"Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC","volume":" ","pages":"219-96"},"PeriodicalIF":1.8,"publicationDate":"2004-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40837547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}